SEC Form 4 · accession 0001179110-18-006662
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Quisel
Officer — EVP, CBO and Secretary
Period of report
May 10, 2018
Accepted (ET)
May 11, 2018 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2018 | A | 2,000 | $0.00 | A | 58,598 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $34.94 | May 10, 2018 | A | 10,000 | A | — | May 10, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The options of registrant's common stock vest in equal quarterly installments over the first four years after the grant.